Q1. It was good to see executive chair Paul Hopper participating in the capital raising earlier this year. Could he please briefly summarise his history of dealing in our shares. Has he spent more money buying our shares over than years than he has realised from selling them?
Answer: The chair... Watch video of exchange via Twitter.
Q2. Why do you keep asking for an extra 10% placement capacity and what is your history in terms of doing placements with no SPP? Shareholders generally don't like this. Next time you raise capital, will you consider doing a pro-rata issue which treats all shareholders equally, rather than issuing as much as 25% of the company's shares to whoever you like, potentially diluting existing shareholders without compensation.
Answer: The chair... Watch video of exchange via Twitter.
Q3. Did we use a recruitment firm to source our new directors being elected for the first time at today's AGM and was it a genuinely competitive process?
Answer: The chair... Watch video of exchange via Twitter.
Q4. There was a 26% protest vote against the election of Dr Charmaine Gittleson at the recent Polynovo AGM. Is Dr Gittleson aware of what the issue, could she share the information with us Imugene shareholders today and has there been a protest vote against her election today?
Answer: The chair... Watch video of exchange via Twitter.Below is the text of the 4 written questions submitted at the ????? hybrid AGM held at on November ??? 2026 and via the ???. See notice of meeting detailing ???? resolutions. Market cap was ???? on AGM day. The proxies were disclosed early in the formal addresses. There were no protest votes.
Copyright © 2026 The Mayne Report. All rights reserved